Search

Your search keyword '"Skantze, Pia"' showing total 12 results
Start Over Author "Skantze, Pia"
12 results on '"Skantze, Pia"'

1. pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function

Author

Philipp, Julian, primary, Dabkowska, Aleksandra, additional, Reiser, Anita, additional, Frank, Kilian, additional, Krzysztoń, Rafał, additional, Brummer, Christiane, additional, Nickel, Bert, additional, Blanchet, Clement E., additional, Sudarsan, Akhil, additional, Ibrahim, Mohd, additional, Johansson, Svante, additional, Skantze, Pia, additional, Skantze, Urban, additional, Östman, Sofia, additional, Johansson, Marie, additional, Henderson, Neil, additional, Elvevold, Kjetil, additional, Smedsrød, Bård, additional, Schwierz, Nadine, additional, Lindfors, Lennart, additional, and Rädler, Joachim O., additional

Published
2023
Full Text
View/download PDF

6. Nanocrystal formulations of a poorly soluble drug. 2. Evaluation of nanocrystal liver uptake and distribution after intravenous administration to mice

Author

Sigfridsson, Kalle, primary, Skantze, Pia, additional, Skantze, Urban, additional, Svensson, Lena, additional, Löfgren, Lars, additional, Nordell, Pär, additional, Michaëlsson, Erik, additional, Smedsrød, Bård, additional, Fuglesteg, Britt, additional, Elvevold, Kjetil, additional, and Lindfors, Lennart, additional

Published
2017
Full Text
View/download PDF

11. Amorphous Drug Nanosuspensions. 2. Experimental Determination of Bulk Monomer Concentrations

Author

Lindfors, Lennart, Forssén, Sara, Skantze, Pia, Skantze, Urban, Zackrisson, Anna, and Olsson, Ulf

Abstract

A simple turbidimetric method was developed to measure the bulk concentration of drug in nanosuspensions. The bulk concentrations measured were in the range from 1 μM to 1 mM. The accuracy of the method was checked by determination of the bulk concentration of crystalline nanosuspensions, i.e., the crystalline solubility, which compared favorably to solubilities measured by a conventional method. Results obtained for amorphous nanosuspensions agreed with predictions using a theory describing the relative solubility between a supercooled liquid and a crystal. Further, it was found that the bulk concentration in Ostwald ripening inhibited amorphous nanosuspensions and could be lowered by incorporation of higher amounts of the inhibitor, in agreement with predictions using the Bragg−Williams theory of nonideal solutions.

Published
2006
Full Text
View/download PDF

12. Amorphous Drug Nanosuspensions. 1. Inhibition of Ostwald Ripening

Author

Lindfors, Lennart, Skantze, Pia, Skantze, Urban, Rasmusson, Mikael, Zackrisson, Anna, and Olsson, Ulf

Abstract

Amorphous drug nanosuspensions are prone to particle growth due to Ostwald ripening. By incorporating a second component of extremely low aqueous solubility, Ostwald ripening can be inhibited. These studies indicate that to inhibit ripening, the drug/inhibitor mixture (in the particles) must form a single phase. The drug/inhibitor mixture can be characterized by the interaction parameter χ using the Bragg-Williams theory, in which single phase mixtures are obtained for χ < 2. The χ parameter can be calculated from the (crystalline) solubility of the drug in the inhibitor, provided the inhibitor is a liquid, and the melting entropy and temperature of the drug.

Published
2006
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results